2016 Q3/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +7 Wockhardt
7.5
2 +0 Neurocrine Biosciences
7.2
3 +2 Yakult UK
7.1
4 +17 Julphar
7.1
5 +6 Kaken Pharmaceutical
7.1
6 -2 Kyorin Holdings
6.9
7 +76 Cytogen
6.8
8 +10 Taisho Pharmaceutical
6.7
9 +1 Mitsubishi Tanabe
6.7
10 -7 Galenica AG
6.7
11 +5 Meda Pharmaceuticals
6.7
12 -3 MediGene
6.7
13 +7 Anika Therapeutics
6.6
14 +0 Abbott Uk
6.5
15 -9 Biotecnol
6.5
16 -1 Abbott
6.3
17 +50 Lundbeck
6.3
18 -1 Baxter International
6.1
19 -7 Nissan Chemical
6.1
20 +36 Genmab
6.1
21 +50 Laboratoires Thea UK
6.1
22 +2 Mitsubishi Tanabe Pharma Europe Ltd
6.1
23 +19 Nippon Chemiphar
6.0
24 -5 Actelion
6.0
25 -18 Bavarian Nordic
6.0
26 +7 CinnaGen
5.9
27 +73 QLT
5.9
28 +0 Debiopharm
5.9
29 +2 EISAI UK
5.8
30 -3 Pfizer UK
5.7
31 -6 Merz
5.7
32 -10 EISAI
5.6
33 +4 Hospira
5.6
34 +48 Ipsen UK
5.6
35 +29 United Therapeutics
5.5
36 -2 Dainippon Sumitomo
5.5
37 -7 Forest
5.5
38 +16 Toray Industries
5.4
39 +42 Gruenenthal
5.4
40 +3 Agennix
5.2
41 +7 Stallergenes UK
5.2
42 +7 Cipla
5.2
43 -11 Mochida
5.2
44 +6 Vitrolife
5.1
45 +33 Boehringer Ingelheim
5.1
46 -10 Covence
5.1
47 -9 Genzyme UK
5.1
48 +7 Galderma
5.0
49 +8 Apotex
5.0
50 -10 Asahi Kasei
5.0


Changes in rank are compared to 2016 Q2/Global Life Sciences. Since then, 3 sites entered the survey and 49 sites could not be included in the rankings (1 more since last time). Build your own. Report statistics.